A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
In a bombshell announcement made last week, the Food and Drug Administration (FDA) said it will ban the use of FD&C Red No. 3 ...
Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
Northwell Health partnered with Stacker to explore how a new Pap smear alternative may help prevent deaths from cervical ...
As part of the second Trump Administration's diversity witchhunt, cancer research and other crucial projects have been paused ...
The FDA banned Red No.3, also known as erythrosine, after reviewing studies that linked high doses of the dye to cancer in ...
Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...
The second CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" for blood ...